Journal
NEURO-ONCOLOGY
Volume 20, Issue 9, Pages 1162-1172Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nox242
Keywords
BEST glossary; biomarkers; endpoints; glioma; outcomes
Categories
Ask authors/readers for more resources
In early 2016, the FDA and the National Institutes of Health (NIH) published the first version of the glossary included in the Biomarkers, EndpointS, and other Tools (BEST) resource. 1 The BEST glossary was constructed to harmonize and clarify terms used in translational science and medical product development and to provide a common language used for communication by those agencies. It is considered a living document that will be updated in the future. This review will discuss the main biomarker and clinical outcome categories contained in the BEST glossary as they apply to neuro-oncology, as well as the overlapping and hierarchical relationships among them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available